Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

help us with this process we have hired BroadOak Capital Partners, an investment bank with a comprehensive focus on the life sciences industry.

  1. We are working on licensing agreements for Multikine to pay for the Phase III trial because raising the amount of money required for the trial at the current prices would be harmful to our shareholders;
  2. We are working on a joint venturing agreement for the same reason;
  3. We are in discussions to use our manufacturing facility as a contract manufacturing facility while it is not being used to produce Multikine;
  4. We have also signed a $5 million line of credit to be used if necessary. This line is not intended to be our primary funding source but does serve as additional insurance to shareholders;
  5. We have a few other, some of them "out of the box" ideas, ongoing.

We hope to bring at least one of these projects to a conclusion very soon.

We cannot change the economic climate or the damage that the financial crisis has caused to the countless stocks, us included, but we are trying to structure our future steps to create the greatest value for CEL-SCI shareholders. We are being very careful and deliberate, working closely with our various partners, suppliers, etc as we adapt to the current environment.

We believe that as a cancer company ready to start a pivotal Phase III clinical trial with a completely novel and non-toxic cancer therapy, we are well positioned for licensing, joint venture and other business arrangements. In normal times these deals might already have been completed a while ago and we would have already started the Phase III trial. In the last few months almost all investments have been hit hard and everything just seems to take longer. Our valuation is currently very low. However, please do not confuse our share price with th
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... -- RnRMarketResearch.com adds "Pemphigus - Pipeline ... 68 pages with latest updates, data and information ... The report "Pemphigus - Pipeline Review, H1 2015" report provides ... Pemphigus , complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:3/31/2015)... 31, 2015 Ryan & Maniskas, LLP ... directors of Hyperion Therapeutics, Inc. ("Hyperion" or the "Company") ... duty and other violations of law related to the ... plc in a transaction valued at approximately $1.1 billion. ... would like to learn more about this class action ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2
... Jan. 13, 2011 CareGiver remote instrument support has ... Ventana Medical System, Inc. ("VMSI") is the leading innovator ... over 5 years of success on the SYMPHONY H&E ... on BenchMark ULTRA, strengthening the integration of the SYMPHONY ...
... The U.S. Food and Drug Administration is asking ... limit the amount of acetaminophen to no more than ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... of all prescription combination acetaminophen products to warn of ...
Cached Medicine Technology:CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer 2CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer 3FDA Limits Acetaminophen in Prescription Combination Products; Requires Liver Toxicity Warnings 2
(Date:3/31/2015)... 31, 2015 Clinovo, a leading ... Membership Program , the premiere voice of Northern ... life science companies. , BayBio brings together ... most innovative and productive life science cluster, helping ... of humanity’s most pressing challenges. , “We ...
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Healthpointe’s ... hip injuries at all of their clinics. Specialties include ... disorders. , For athletes with hip injuries, Healthpointe ... to assess and treat the symptoms and underlying causes ... provide minimally-invasive care and prevent future damage, while taking ...
(Date:3/31/2015)... 2015 Former 49ers linebacker Chris Borland turned ... first year of a promising NFL career. In a March ... Senior Writer Will Leitch explores the curious case of ... about the decision making process that Borland and other football ... over a large paycheck, and what impact, if any, he ...
(Date:3/31/2015)... Seattle, WA (PRWEB) March 31, 2015 ... health insurance exchange technology, has announced that Lance Hood, ... for HealthCare Consumerism Private Exchange Forum on April 1, ... Business Development of Benaissance, will address how employers can ... management process. , WHAT: “ Optimizing Employee and ...
(Date:3/31/2015)... As the scientific community gathers at Experimental Biology ... is poised to make meaningful contributions to the broader ... a network of scientists from North America, Latin America ... have banded together to further the understanding of the ... and apply this understanding to develop novel approaches to ...
Breaking Medicine News(10 mins):Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3
... DALLAS, Jan. 12 Affiliated Computer Services, Inc. (NYSE: ... provide Regence with Health Savings Account (HSA) administration services ... counties of Washington. Regence members will be offered the ... the addition of Regence, the largest health insurer in ...
... 12 , - Small ... , With the introduction of ... messaging device, NEC sets new standards in,mobile communications and ... innovations. , (Photo: http://www.newscom.com/cgi-bin/prnh/20090112/333834 ...
... publication of its kind aimed at healthcare fraud ... (HCI), a Verisk HealthCare company and a provider ... solutions for healthcare claims payors, announced today that ... Profiler Magazine is the nation,s ...
... Jan. 12 Wyeth Pharmaceuticals, a division of Wyeth ... announced that the companies have entered into a worldwide ... based on Santaris Pharma,s proprietary Locked Nucleic Acid (LNA) ... microRNAs (miRNAs) and messenger RNAs (mRNAs) as a means ...
... Corporation,(Nasdaq: ALUS ), the worldwide leader ... patients, today announced preliminary,unaudited record fourth quarter and ... Fourth quarter 2008 revenue improved ... of approximately $3.8 million, compared with $2.7 million ...
... to Drive Real-Time Pharmacy Utilization Management DecisionsNEWPORT ... The TriZetto Group, Inc. and Sanovia Corporation ... offer the market,s first platform that integrates ... automate prior-authorizations of medications and help plans ...
Cached Medicine News:Health News:ACS to Provide HSA Product to Regence; ACS HSA Solution Now Offered by Blue Cross Blue Shield Plans in 28 States 2Health News:NEC's new M155 Messenger Sets New Standards in Mobile Messaging 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2Health News:Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines 2Health News:Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines 3Health News:Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines 4Health News:Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue 2Health News:Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue 3Health News:TriZetto, Sanovia Join Forces to Offer First Integrated Platform That Helps Payers Control Pharmacy Costs 2Health News:TriZetto, Sanovia Join Forces to Offer First Integrated Platform That Helps Payers Control Pharmacy Costs 3
Used when establishing a percutaneous tract for nephrostomy drainage. The wire guide has an extra stiff shaft and a gradual transition to a very flexible tip. Supplied sterile in peel-open packages. ...
Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Used over a wire guide for cutting the renal fascia to facilitate dilation of a musculofascial tract. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: